ATE291033T1 - Therapeutische peptide - Google Patents

Therapeutische peptide

Info

Publication number
ATE291033T1
ATE291033T1 AT01946869T AT01946869T ATE291033T1 AT E291033 T1 ATE291033 T1 AT E291033T1 AT 01946869 T AT01946869 T AT 01946869T AT 01946869 T AT01946869 T AT 01946869T AT E291033 T1 ATE291033 T1 AT E291033T1
Authority
AT
Austria
Prior art keywords
type
ifn
seq
analogues
terminus
Prior art date
Application number
AT01946869T
Other languages
English (en)
Inventor
Michael Gerard Tovey
Pierre Eid
Original Assignee
Medarex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medarex Inc filed Critical Medarex Inc
Application granted granted Critical
Publication of ATE291033T1 publication Critical patent/ATE291033T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7156—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT01946869T 2000-01-25 2001-01-25 Therapeutische peptide ATE291033T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0001712.9A GB0001712D0 (en) 2000-01-25 2000-01-25 Therapeutic peptides
PCT/GB2001/000287 WO2001055215A1 (en) 2000-01-25 2001-01-25 Therapeutic peptides

Publications (1)

Publication Number Publication Date
ATE291033T1 true ATE291033T1 (de) 2005-04-15

Family

ID=9884323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01946869T ATE291033T1 (de) 2000-01-25 2001-01-25 Therapeutische peptide

Country Status (10)

Country Link
US (2) US20040067888A1 (de)
EP (1) EP1250358B1 (de)
JP (1) JP2003525040A (de)
AT (1) ATE291033T1 (de)
AU (1) AU2865801A (de)
CA (1) CA2397267A1 (de)
DE (1) DE60109412T2 (de)
ES (1) ES2240475T3 (de)
GB (1) GB0001712D0 (de)
WO (1) WO2001055215A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
ATE517920T1 (de) 2003-04-23 2011-08-15 Medarex Inc Humanisierte antikörper gegen interferon-alpha- rezeptor-1 (ifnar-1)
EP1631312B1 (de) * 2003-04-23 2008-09-10 Medarex, Inc. Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung
DK2662390T3 (da) 2004-06-21 2017-11-06 Squibb & Sons Llc Interferon alpha receptor 1-antistoffer og anvendelse heraf
NZ554065A (en) * 2004-10-07 2010-12-24 Univ Zuerich Use of an anti-interferon-alpha antibody for prevention and treatment of psoriasis
BRPI0607490A2 (pt) 2005-02-10 2009-09-08 Baylor Res Inst anticorpos monoclonais antiinterferon alfa e métodos para uso
CA2722622C (en) * 2008-05-07 2018-01-02 Novo Nordisk A/S Humanized antibodies against human interferon-alpha
DK2863955T3 (en) 2012-06-26 2017-01-23 Sutro Biopharma Inc MODIFIED FC PROTEINS, INCLUDING LOCATION-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, CONJUGATES THEREOF, METHODS OF PRODUCING ITS AND PROCEDURES FOR USE THEREOF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
EP0563487A1 (de) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon

Also Published As

Publication number Publication date
CA2397267A1 (en) 2001-08-02
US20040067888A1 (en) 2004-04-08
JP2003525040A (ja) 2003-08-26
US20070042963A1 (en) 2007-02-22
DE60109412T2 (de) 2006-04-13
EP1250358A1 (de) 2002-10-23
ES2240475T3 (es) 2005-10-16
GB0001712D0 (en) 2000-03-15
WO2001055215A1 (en) 2001-08-02
EP1250358B1 (de) 2005-03-16
DE60109412D1 (en) 2005-04-21
AU2865801A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
RS52815B (sr) Vezivna sredstva koja inhibiraju miostatin
DK1531791T3 (da) Forebyggelse og begrænsning af iskæmi
DE69838143D1 (de) Antimikrobielle peptide
JP2005519059A5 (de)
ATE291033T1 (de) Therapeutische peptide
EP1092727A3 (de) G-protein rezeptor
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
ATE362939T1 (de) Dimere von thrombinpeptidderivaten
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
WO2003070751A3 (en) Partial peptide mimetics and methods
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
DK0853484T3 (da) Hidtil ukendte MU-opioid-receptorligander: agonister og antagonister
GB9416536D0 (en) Orphan receptor
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
ATE375390T1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
WO2002038607A3 (en) A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
DE60325227D1 (de)
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof
EP1096008A3 (de) Menschlicher G-Protein-gekoppelter Rezeptor, PFI-014
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
EP1094109A3 (de) Menschlicher G-Protein-gekoppelter Rezeptor, PFI-010
EP1225183A3 (de) Humaner G-Protein gekoppelter Rezeptor
WO2002092624A3 (en) G-protein coupled receptor
WO2003033536A3 (en) G-protein coupled receptor
WO2004043994A3 (en) A retro-inverso gonadotropin-releasing hormone peptide and vaccine composition

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties